Biosimilars of Rituximab in ANCA-associated Vasculitis Compared to the Originator

Active, not recruitingOBSERVATIONAL
Enrollment

201

Participants

Timeline

Start Date

June 15, 2021

Primary Completion Date

September 15, 2025

Study Completion Date

September 15, 2025

Conditions
ANCA-associated VasculitisGranulomatosis With PolyangiitisMicroscopic Polyangiitis
Trial Locations (9)

Unknown

University of Calgary, Calgary

University of Alberta, Edmonton

University of British Columbia (Vancouver Coastal Health Authority), Vancouver

St Joseph's Healthcare Hamilton (McMaster University), Hamilton

Lawson Research Institute (Western University), London

Ottawa Hospital Research Institute (Ottawa University), Ottawa

Sinai Health System (University of Toronto), Toronto

Centre Intégré Universitaire de Santé et de Services Sociaux du Nord-de-l'île-de-Montréal (CIUSSS NÎM) / Hôpital du Sacré-Coeur de Montréal, Montreal

H3G 1A4

McGill University (Montreal General Hospital), Montreal

Sponsors
All Listed Sponsors
collaborator

Sinai Health System

OTHER

collaborator

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER

collaborator

Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal

OTHER

collaborator

St. Joseph's Healthcare Hamilton

OTHER

collaborator

University of Calgary

OTHER

collaborator

University of British Columbia

OTHER

collaborator

University of Alberta

OTHER

collaborator

Ottawa Hospital Research Institute

OTHER

collaborator

CAnadian Network for Advanced Interdisciplinary Methods for comparative effectiveness research

UNKNOWN

collaborator

Canadian Initiative for Outcomes in Rheumatology Care

OTHER

lead

McGill University Health Centre/Research Institute of the McGill University Health Centre

OTHER